Media Summary: ... coming forward that we haven't talked about in each of your areas but I first want to just we had a question on Moving beyond acute lymphoblastic leukemia (ALL), experts review the use of Earn CME for related activities: In this webcast from the '
Mrd Testing In Hematologic Malignancies - Detailed Analysis & Overview
... coming forward that we haven't talked about in each of your areas but I first want to just we had a question on Moving beyond acute lymphoblastic leukemia (ALL), experts review the use of Earn CME for related activities: In this webcast from the ' Read the full interview on Oncology Data Advisor: Paolo Ghia, MD, Università Vita-Salute San Raffaele, Milan, Italy, discusses the use of measurable residual disease ( In this video series that was recorded in November 2025, leading oncologists present patients and caregivers with the most ...
This video provides a clear, structured overview of companion diagnostics (CDx) and molecular residual disease ( Jerald P. Radich, MD, member, Clinical Research Division, Kurt Enslein Endowed Chair, Fred Hutchinson Learn more about Minimal Residual Disease ( Nicole Gormley, MD, FDA, Silver Spring, MD, discusses the updated measurable residual disease ( This video provides highlights from the first half of the Invivoscribe corporate workshop, Naval G. Daver, MD, oncologist, Department of Leukemia, The University of Texas MD Anderson
Jerald P. Radich, MD, discusses measuring This video provides highlights from the second half of the Invivoscribe corporate workshop, In this installment of Chief Insights in Oncology, John M. Burke, MD, co-editor in chief of Targeted Therapies in Oncology, ... Recorded on April 12, 2022 as part of the
